Newcastle, DE, United States of America

Jianji Wang

This inventor holds 4 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Incyte Corporation, Incyte Holdings Corporation. Active years: 2019-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jianji Wang. Retrieved from https://idiyas.com/inventor/jianji-wang-6yr0havv

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 4 

% Patents Active = 100.0

 

Average Co-Inventor Count = 7.6

ph-index = 2

Forward Citations = 20(Granted Patents)


Company Filing History:


Years Active: 2019-2024

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Sure, here is the article about inventor Jianji Wang:

Title: Unveiling the Inventive Path of Jianji Wang

Introduction: Meet Jianji Wang, a talented inventor hailing from New Castle, DE (US), who has made significant contributions to the field of pharmaceuticals with his innovative patents.

Latest Patents:

1. **Processes of Preparing a JAK1 Inhibitor:** Jianji Wang's patent outlines processes for synthesizing a selective JAK1 inhibitor, opening new avenues in the treatment of various diseases.

2. **Salts and Processes of Preparing a PI3K Inhibitor:** Another remarkable patent by Jianji Wang focuses on developing a PI3K inhibitor, showcasing his expertise in pharmaceutical research and development.

Career Highlights: Jianji Wang is a key figure at Incyte Corporation, a renowned player in the pharmaceutical industry, where he applies his knowledge and skills to drive groundbreaking innovations.

Collaborations: Throughout his career, Jianji Wang has collaborated with esteemed professionals in the field, such as Zhongjiang Jia and Jiacheng Zhou, showcasing his ability to work effectively in a team and foster creativity.

Conclusion: Jianji Wang stands as a beacon of innovation in the realm of pharmaceuticals, with his patents shaping the future of medical treatments. His dedication to research and collaboration exemplifies the spirit of progress and advancement in the industry.

If you need more information or have any specific requests, feel free to let me know.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…